Margret Leosdottir on Statin–Ezetimibe Algorithm Dramatically Improving Post-MI LDL-C Outcomes
Margret Leosdottir, Senior cardiology consultant at Skane University Hospital, shared on LinkedIn:
”At Skåne University Hospital in Malmö, in November 2022 we launched an algorithm to support our CCU doctors to prescribe lipid-lowering therapy during ACS hospitalization, focused on increasing the use of ezetimibe for patients not expected to reach goal on high-dose atorvastatin alone.
The algorithm was inspired by prior work from France under the lead of Prof François Schiele.
In just a couple of months, at our hospital the proportion of patients reaching LDL-C goal at 2-months post-MI increased from 30% to 55%.
This increase has remained since, with approximately 65% of our patients now at goal at one-year post-MI
Today we launch a new version of the algorithm, switching primary choice of high-intensity statin to rosuvastatin and further adapting recommendations to the 2025 European Society of Cardiology and European Atherosclerosis Society Lipid GL update.
Failure to implement evidence-based medicine is a major cause of concern in today´s healthcare.
Often simple measures like these can carry us a long way, improving prognosis for our patients and making better use of limited healthcare resources.
The example also shows the usefulness of national registries like SWEDEHEART to track progress and benchmark quality improvement efforts at your clinic
With Emil Hagström and Jessica Schubert.”
Stay updated with Hemostasis Today.
-
Jun 8, 2026, 13:27Emile Hung: Why Nutrition Should Be Central to Vascular Disease Prevention
-
Jun 8, 2026, 12:21William Aird: Developing Patient-Facing Educational Material for The Blood Project
-
Jun 8, 2026, 12:02Glanzmann Thrombasthenia – A Rare but Important Platelet Disorder – Iranian Comprehensive Hemophilia Care Center
-
Jun 8, 2026, 06:30Caryn Blumenfeld: Team Zakophilia and Ratner’s Runners Even Though It’s A Walk!
-
Jun 8, 2026, 06:25Cécile Jefford: The NEHA Community and the Power of Human Connection
-
Jun 8, 2026, 06:02Manoj K: How Incyte Could Help Transform Care for Patients With von Willebrand Disease
-
Jun 8, 2026, 03:05Shamsunisha Yusuff: Iron Down, Platelets Up in a Young CBC ?
-
Jun 8, 2026, 03:03Samwel Mikaye: D-Dimer – A Marker of Blood Clot Breakdown
-
Jun 8, 2026, 02:59Vinita Madhuri: Our Engagement, A Lifeline for Thalassemia Patients